BILL vs COLL · rev $1.46B vs P/E 17, rev $181.9M
Bill Com Holdings Inc (BILL) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Bill Com Holdings Inc (BILL) is a software - application company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported BILL revenue for 2025-06-30 was $1.46B. Net income was $23.8M. Revenue was up 13.4% from 2024-06-30 to 2025-06-30. BILL currently screens at market cap $4.78B.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
BILL currently screens at market cap $4.78B. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the BILL and COLL stock pages for the full models.
Not investment advice.